sodium pyrophosphate has been researched along with Vascular Calcification in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barreto, FC; Benchitrit, J; de Oliveira, RB; Drüeke, TB; Jorgetti, V; Louvet, L; Massy, ZA; Poirot, S; Rezg, R; Riser, BL | 1 |
| Barreto, FC; Cook, CS; Drueke, TB; Gass, JH; Holmes, CJ; Louvet, L; Maizel, J; Massy, ZA; Rezg, R; Riser, BL; Valaitis, PW; White, JA | 1 |
2 other study(ies) available for sodium pyrophosphate and Vascular Calcification
| Article | Year |
|---|---|
Peritoneal delivery of sodium pyrophosphate blocks the progression of pre-existing vascular calcification in uremic apolipoprotein-E knockout mice.
Topics: Animals; Apolipoproteins E; Diphosphates; Disease Models, Animal; Disease Progression; Infusions, Parenteral; Mice; Mice, Knockout; Renal Insufficiency, Chronic; Uremia; Vascular Calcification | 2015 |
Daily peritoneal administration of sodium pyrophosphate in a dialysis solution prevents the development of vascular calcification in a mouse model of uraemia.
Topics: Animals; Apolipoproteins E; Calcium; Dialysis Solutions; Diphosphates; Female; Half-Life; Male; Mice; Mice, Knockout; Peritoneal Dialysis; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Tissue Distribution; Uremia; Vascular Calcification | 2011 |